Our results suggested that HER-2/neu, as a potential upstream regulatory molecule in the COX-2/PGE2/P450arom signaling pathway, could play a critical role in estrogen-dependent endometrial carcinoma. The gene discussed is ERBB2; the disease is endometrial carcinoma.